Previous 10 | Next 10 |
Horizon Pharma plc (NASDAQ: HZNP ) has priced its public offering of ~12.2M ordinary shares at $24.50 per share. Underwriters over-allotment is an additional ~1.8M shares. Closing date is March 11. More news on: Horizon Pharma plc, Healthcare stocks news, Stocks on the move, Read mor...
-- Offering size of $300 million -- -- Offering proceeds, along with balance sheet cash, expected to fund a debt reduction of ~$550 million -- Horizon Pharma plc (Nasdaq: HZNP) today announced the pricing of its underwritten public offering of 12,244,898 of its ordinary shares at...
Horizon Pharma (NASDAQ: HZNP ) is off 2.6% in late trading after noting in a filing that it received a demand from the Justice Dept. related to payments. More news on: Horizon Pharma plc, Healthcare stocks news, Stocks on the move, Read more ...
Horizon Pharma plc (NASDAQ: HZNP ) launches a $300M public offering of ordinary shares. Underwriters over-allotment is an additional $45M of stock. Price, volume and terms have yet to be announced. More news on: Horizon Pharma plc, Healthcare stocks news, Stocks on the move, Read mor...
Offering size of $300 million Offering proceeds, along with balance sheet cash, expected to fund a debt reduction of ~$550 million Horizon Pharma plc (Nasdaq: HZNP) today announced that it is offering to sell $300,000,000 of its ordinary shares in an underwritten public ...
Horizon Pharma plc (Nasdaq: HZNP) today announced that the compensation committee of its board of directors approved the grant on March 1, 2018 of inducement restricted stock units for an aggregate of 8,544 ordinary shares to six new employees. The restricted stock units vest over three ...
Gainers: Arcadia Biosciences (NASDAQ: RKDA ) +83% . Horizon Pharma Public (NASDAQ: HZNP ) +30% . J. C. Penney Company (NYSE: JCP ) +27% . Sequential Brands Group (NASDAQ: SQBG ) +28% . Triple-S Management (NYSE: GTS ) +25% . TG Therapeutics (NASDAQ: TGTX ) +21% . T2 Biosystems ...
Sequential Brands (NASDAQ: SQBG ) +52% as Martha Stewart to advise Canopy Growth and Sequential Brands on CBD marketing . More news on: Sequential Brands Group, Inc., Arcadia Biosciences, Horizon Pharma plc, Stocks on the move, Read more ...
Horizon Pharma plc (NASDAQ: HZNP ) is up 23% premarket on average volume in response its successful Phase 3 clinical trial, OPTIC , evaluating teprotumumab in patients with active thyroid eye disease (TED). The study met the primary endpoint of a statistically significant prop...
- Demonstrated dramatic reduction in proptosis, or eye bulging, the main cause of morbidity in TED - - There are no FDA-approved treatments available for TED, a devastating rare eye disease that affects 15,000 to 20,000 people each year in the United States - - Continue to expect ...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Horizon Therapeutics Public Limited Company Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...